SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is currently trending as the community eagerly awaits the launch of its BlueBird 7 satellite, with excitement fueled by potential partnerships and a notable push toward critical commercial milestones. Investors are actively debating the stock's future valuation and technical setup, balancing optimism for upcoming mission success against skepticism regarding the company's communication and launch cadence.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as investors react to high-volume trading and aggressive call option activity, fueling debates about a potential gamma squeeze and the firm's role in the AI data center supply chain. While some users are frustrated by persistent volatility and a lack of immediate commercial updates, the broader community remains focused on the company's long-term potential as a critical player in silicon photonics.

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies is trending as investors monitor a definitive agreement with Crypto.com/us to enter the prediction markets sector, with the community actively debating whether the news justifies the recent volatility. Many traders are focused on the stock's low float and potential for a squeeze, though discussions remain polarized between those anticipating a major breakout and others expressing skepticism about the company's ability to execute on its growth strategy.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is facing intense retail debate as traders weigh its strategic role in national quantum infrastructure against concerns over share dilution and broader market volatility. While some investors point to recent DARPA contracts and photonic interconnect milestones as bullish indicators for long-term scalability, others remain skeptical, citing persistent cash burn and ongoing short-selling pressure.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp is seeing significant investor interest following the termination of a controversial financing deal with Yorkville, a move many traders view as the removal of a major dilution overhang. Community sentiment is shifting toward a bullish outlook, with active discussions focusing on potential price recovery, institutional accumulation, and a desire to see the stock catch up with other fintech competitors.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is currently a central focus for traders as the stock experiences intense volatility driven by its critical role in supplying fast-deploying power solutions for AI data centers. While the community is actively debating the stock's massive long-term potential versus concerns of overvaluation and tactical short-selling, many are closely watching key technical levels to determine if the current price action represents a healthy consolidation or a deeper pullback.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum Inc. (QBTS) is currently drawing intense investor attention due to its dual-platform approach to quantum computing and recent speculative momentum, though the stock remains a flashpoint for debate between bulls betting on its long-term defense and optimization potential and bears highlighting the company's lack of consistent profitability. The community is actively dissecting the firm's competitive positioning relative to industry rivals and larger tech players, with traders closely monitoring technical support levels amid heightened volatility.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors digest news regarding a long-standing patent dispute with AIXI in China, alongside ongoing discussions about the company's potential integration of satellite technology and its future AI strategy. The community remains divided, with many traders frustrated by the stock's recent price stagnation compared to the broader market while others focus on long-term growth catalysts like foldable devices and services revenue.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is currently trending as investors focus on the public launch of its Power Packs digital trading card platform while tracking high-profile insider activity and institutional positioning. The community remains deeply divided, with some users anticipating a potential short squeeze amid discussions of manipulation, while others express frustration over the stock's recent price consolidation.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is surging following reports that Amazon is in advanced talks to acquire the company, fueling intense community speculation about a potential bidding war involving SpaceX. Investors are actively debating the true valuation of Globalstar's spectrum assets and the impact of Apple's existing strategic partnership on deal terms.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>REPL came under pressure after the FDA issued a second Complete Response Letter for RP1 with nivolumab in anti-PD-1-failed melanoma.</li><li>HOTH declined after a $2 million stock offering, along with attached warrants, raised dilution concerns despite recent pipeline updates.</li><li>ONCO is on a major slide after its reverse stock split, while its pending all-stock acquisition of Realbotix has yet to improve investor sentiment.</li></ul>Shares of Replimune (REPL), Hoth Therapeutics (HOTH), and Onconetix (ONCO) hit fresh 52-week lows on Monday following an FDA setback, a discounted offering, and a reverse split that underscored listing-compliance pressure.&nbsp;On Monday,&nbsp;<a href="https://stocktwits.com/symbol/REPL">REPL</a> fell 64%,&nbsp;<a href="https://stocktwits.com/symbol/HOTH">HOTH</a> slipped 1% and&nbsp;<a href="https://stocktwits.com/symbol/ONCO">ONCO</a> declined 27%, while the Health Care Select Sector SPDR Fund (XLV) rose 0.5%.<h2 class="st-heading-2">Regulatory Setback Pressures REPL Shares Again</h2>Pressure on REPL intensified recently after the U.S. Food and Drug Administration (FDA) issued a second Complete Response Letter (CRL) for its lead drug RP1 in combination with Nivolumab in anti-PD-1-failed melanoma, extending regulatory uncertainty that had already followed an earlier CRL last year.The latest development triggered a wave of&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/repl-stock-on-track-to-hit-all-time-lows-here-s-why-this-analyst-slashed-price-target-by-85/cZJFHklRIMD">analyst downgrades</a> across Wall Street. Jefferies said the company faces “a tough road ahead” following the FDA’s response, while BMO Capital said the CRL “lays bare the lack of alignment with the FDA and Replimune” throughout clinical development and warned the revised regulatory pathway may now require additional trials.JPMorgan called the outcome “disappointing,” adding it had previously believed “the totality of the data for RP1 warranted an approval.”&nbsp;<h2 class="st-heading-2">Stock Offering Weighs On HOTH Stock</h2>HOTH declined after the company announced earlier this month a stock offering priced at $0.7 per share, expected to generate about $2 million in gross proceeds before expenses, along with warrants exercisable at $0.85.The financing overshadowed pipeline updates over the past month, when the company reported interim Phase 2 progress for HT-001, a topical therapy to treat skin toxicities caused by epidermal growth factor receptor (EGFR) inhibitor cancer treatments. The trial showed that patients reached the primary efficacy endpoint by the sixth week and demonstrated “strong patient benefit across multiple clinically meaningful measures.”&nbsp;However, shares caught a break in after-hours trading on Monday, jumping over 60%, after preclinical data showed its&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-hoth-stock-up-after-hours-today/cZJ8gnKRIuz">HT-VA (GDNF) therapy</a> improved key gene markers linked to fat production and metabolism and outperformed Novo Nordisk's semaglutide on liver-fat regulation signals.<h2 class="st-heading-2">ONCO Slides Despite Realbotix Merger Progress</h2>ONCO shares have remained weak since the company implemented a 1-for-5 reverse stock split, effective March 25, to maintain compliance with Nasdaq’s minimum bid price requirement.The reverse split followed a September equity raise of $12.9 million through Series D preferred stock and warrants, with proceeds used in part to reduce outstanding debt and support working capital following the termination of a previously planned merger with Ocuvex.In February, the company entered into an agreement to acquire Realbotix in an all-stock transaction expected to close in the second half of 2026. Realbotix reported delivering its first Vinci-equipped humanoid robot to Ericsson this month and said the platform enables robots to “recognize returning users, recall previous conversations, and track engagement.” The company expects deliveries of 19 robots across March, April and May as production scales.<h2 class="st-heading-2">How Do Retail Traders Feel About REPL, HOTH, ONCO?</h2>On Stocktwits, retail sentiment for REPL was ‘bearish’ amid ‘extremely high’ message volume, while sentiment for both HOTH and ONCO remained ‘extremely bullish,’ also accompanied by ‘extremely high’ message volume.Over the past year, REPL has fallen 77%, HOTH down 36% and ONCO declining 97%, with all three stocks underperforming the broader XLV ETF, which rose 10% over the same period.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/immunitybio-founder-fda-warning-letter-anktiva-ad-never-aired/cZJpYnYRIHR">ImmunityBio Founder Pushes Back After FDA Warning Letter Over Anktiva Claims — Says Ad 'Never Aired At All'</a>

On Monday alone, REPL plunged 64%, ONCO dropped 27%, and HOTH slipped 1%. (Photo credit: Getty Images)

REPL, HOTH, ONCO Stocks Hit 52-Week Lows: What's Driving The Selloff In These Biotech Plays?

On Monday alone, REPL plunged 64%, ONCO dropped 27%, and HOTH slipped 1%, underperforming the broader XLV healthcare ETF.

Equity

These Stocks are Heating Up Fast

Top stocks to trade this afternoon. $ONCO, $KBLB, $ARAI, $EOSE, $ZNTL

Onconetix Stock Skyrockets After Realbotix Ships Vinci-Equipped Robot To Ericsson

Onconetix shares are surging Thursday afternoon after the company highlighted a product milestone from Realbotix, the pending acquisition target it agreed to buy in an all-stock deal.read more...

These Stocks are Turning Heads

A wave of innovation across AI robotics, biotechnology, advanced materials, and clean energy is reshaping the small-cap landscape. $ONCO, $KBLB, $ELAB, $GLMD, $TURB, $GAME

Promising Biotech Stocks To Add to Your Watchlist - March 27th

Danaher, Onconetix, Moderna, argenex, Vertex Pharmaceuticals, Abivax, and Rocket Pharmaceuticals are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...

What's Going On With Onconetix Shares On Friday?

Onconetix (ONCO) shares surge 71% premarket following the Realbotix acquisition update and 1-for-5 reverse split.read more...

<ul class="summary-bullets"><li>Onconetix is currently in the process of merging with Realbotix, a robotics company.</li><li>The company announced that Realbotix robots featured in a trial by Ericsson, signaling new business.</li><li>Stocktwits sentiment for ONCO was ‘neutral.’</li></ul>Shares of Onconetix, Inc. (ONCO) surged 50% in premarket trading on Friday, following a 1-for-5 reverse stock split a day earlier and disclosures suggesting that humanoid robotics firm Realbotix – a company it is merging with – may have been purchased by Ericsson.A Realbotix humanoid robot was featured in a live pre-standard 6G over-the-air trial conducted at Ericsson’s U.S. headquarters in Plano, Texas, according to a press release statement from Onconetix.The robot streamed video and interacted in real time over the test network, demonstrating AI-agnostic integration for cloud and network environments.In February, Onconetix agreed to acquire Realbotix through an all-stock share exchange that will give Realbotix’s parent a majority stake of up to 90% in the combined company.&nbsp;The deal, expected to close in the second half of 2026, effectively acts as a reverse merger with Realbotix and marks the company’s pivot from men’s health and oncology diagnostics to AI-powered humanoid robotics.&nbsp;As of the close of Thursday, Onconetix had a market capitalization of $2.3 million.Retail traders on Stocktwits were noticing the surge in ONCO. “I'm in at $5.46; I expect it to reach $10 today,”&nbsp;<a href="https://stocktwits.com/YoSoyY0/message/648716455">said</a> one user. Traders&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.stocktwits.com/BTC_Will_Hit_14K/message/648716327">speculated</a> that the sharp rise could be linked to the stock’s low float.About 5 million shares of ONCO exchanged hands early Friday, five times the stock’s average trading volume. On Stocktwits, the retail sentiment for the ticker remained ‘neutral,’ unchanged from the previous day. Year to date,&nbsp;<a href="https://stocktwits.com/symbol/ONCO">Onconetix shares</a> are down nearly 60%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/micron-stock-extends-slide-despite-hottest-company-nod-from-trump/cZ3uzd4RIlt">Micron Stock Extends Slide Despite ‘Hottest Company’ Nod From Trump</a>&nbsp;

Traders work on the floor of the New York Stock Exchange (NYSE) on March 02, 2026 in New York City. (Photo by Spencer Platt/Getty Images)

Why Is This Micro-Cap Stock Surging 50% In Premarket?

Onconetix shares rallied after a reverse stock split this week. The company announced that Realbotix robots featured in a trial by Ericsson, signaling new business.

Why Is Onco Micro-Cap Stock Surging 50% In Premarket?

Onconetix shares rallied after a reverse stock split this week.


Is Onconetix Inc Gaining or Losing Market Support?

Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer

Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (Realbotix or the Parent Company), a leader in AI-powered humanoid robots, announces it has entered into a definitive agreement with...

Shares of Onconetix, Inc. (ONCO) surged more than 56% on Friday, making it the top gainer across U.S. exchanges, a day after an SEC filing revealed that Altos Venture AG had significantly increased its stake in the company, sending retail investors into a frenzy.Altos reported a 32.5% stake in Onconetix as of Sept. 24, which equates to about 2.7 million shares. This stake was acquired through multiple transactions, including stock conversions. Altos also subscribed to the firm’s debentures worth $5 million.One key transaction involved Altos converting 800,358 shares of Series B Convertible Preferred Stock into common shares.The filing also mentioned that the latest disclosure accounted for ONCO’s recent completion of a 1-for-40 reverse stock split on Sept. 24.Altos had previously disclosed a 5% stake in December 2023, when Onconetix was created through the merger of Blue Water Biotech and Proteomedix AG, a diagnostics-focused oncology company.The merger transformed Onconetix into a cancer-focused business, with a portfolio that includes FDA-approved therapies like Entadfi for benign prostatic hyperplasia (BPH) and Proclarix, a prostate diagnostics test with European CE IVD approval.<figure class="image"><a href="https://stocktwits.com/symbol/ONCO"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ONCO_sentiment_and_message_volume_1c21648129.png" alt="ONCO sentiment and message volume.png" width="1314" height="320"></a><figcaption>ONCO sentiment and message volume Sep 27</figcaption></figure>On Stocktwits, retail sentiment for ONCO skyrocketed to ‘extremely bullish’ (96/100) amid a surge in trading volume and message activity, as investors responded to Altos’ stake hike and potential activism.However, ONCO shares remain down more than 30% year-to-date, indicating a broader recovery might still be needed.Read next: <a href="https://stocktwits.com/news/markets/equity/lvs-wynn-stocks-jump-on-china-stimulus-cheer/c7CUs5uR3T">Las Vegas Sands, Wynn Resorts Stocks Jump After China Stimulus, But Retail Investors Favor Only One</a>

Top US Gainer Onconetix Makes Retail ‘Extremely Bullish’ After VC Firm Boosts Stake

Altos Venture had previously disclosed a 5% stake in December 2023

Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company was founded in October 2018 and is headquartered in Cincinnati, OH.

ONCO
Onconetix Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ONCO News

ONCOOnconetix Inc